The global HPAPI
market was worth USD 9.1 billion in 2011 and is expected to reach USD
17.5 billion in 2018, growing at a CAGR of 9.9% from 2012 to 2018. In
the overall global market, North America accounts for the largest
market share, whereas Asia Pacific is likely to witness highest
growth in the forecasted period. India and China will be the major
countries to register high growth rate in the high potency active
pharmaceutical ingredients (HPAPIs) market due to rising health
awareness, growing economies and improving healthcare systems.
Browse the full
report at High Potency Active Pharmaceutical Ingredients Market
http://www.transparencymarketresearch.com/high-potency-active-pharmaceutical-Ingredients-market.html
High potency active
pharmaceutical ingredients (HPAPIs) are growing rapidly as compared
to other segments of the healthcare industry. HPAPI are the compounds
helpful in the treatment of respiratory disorders, treatment of
cancer and hormonal imbalances. Growing oncology therapeutics market
worldwide is the key factor driving the growth of this market.
High potency active
pharmaceutical ingredients market is a growing concept and is
considered to be a boost to the pharmaceutical industry. Patented
high potency drug development majorly dominates the HPAPI market. The
branded sector constitutes the major share of this market but the
patents of this branded sector are expected to expire in the coming
few years that will help HPAPI manufacturers to cater to multiple
clients by producing the generic version of the ingredients in bulk.
Some of the factors
driving this market at a rapid growth rate are majority of
blockbuster drugs nearing patent expiry, US government promoting
generic drugs to reduce its medical burden, insurance companies
preferring generic drugs over patented drugs for cost effectiveness
and India and China with maximum DMFs with the US FDA.
However, a large
number of competitors are entering this market making it highly
fragmented which may slow down the growth of this market. Moreover,
reduced R&D investments leading to low demand of HPAPIs and
shortage of US FDA approved manufacturing sites are also likely to be
the major restraints for the growth of the high potency active
pharmaceutical ingredients market.
However, North
America has been the largest market for high potency pharmaceutical
ingredients as the country spends highly on the development of
healthcare systems, whereas the European market has experienced
several fluctuations in the past few years but is expected to grow
rapidly in the near future due to rise in the demand of oncology
drugs in this region.
Request for
customization of this report
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=748
Asia Pacific region
is expected to witness high growth in the coming years due to the
production of generics at a significant rate. Currently, the Asia
Pacific region is the second largest market after North America for
HPAPIs and is expected to become the largest market soon. Skilled
manpower and low labor cost are greatly contributing to API
manufacturing and outsourcing combined with research and development.
India and China are the major countries in the Asia Pacific region
expected to witness high growth in the near future.
Some of the major
players of this market are Pfizer, Roche, Novartis, GlaxoSmithkline
Pharmaceuticals Ltd., BASF Se, Hospira Inc., Matrix Laboratories
Limited, Covidein Plc and Astra Geneca International, among others.
This research is
specially designed to estimate and analyze the demand and performance
of high potency active pharmaceutical ingredients in a global
scenario. The research provides in-depth analysis of the HPAPI market
by end use, by application and by type segments and demand by
geography. The report covers all the major product segments of the
High HPAPIs market and provides in-depth analysis, historical data
and statistically refined forecast for the segments covered. The
study presents a comprehensive assessment of the stakeholder
strategies winning imperatives for them by segmenting the HPAPI
market as below:
HPAPI Market,
2012 – 2018
Introduction
HPAPI
Classification as per Safebridge Consultants
Overview: HPAPI
Global Market
Manufacturing Capabilities
- Handling requirements
- Personnel considerations
- Plant & equipment
- Technology
- HPAPI Market, By Type of Synthesis, 2012 – 2018
- Overview
- Sub-Segments Of HPAPI Market
- By Type Of Synthesis
- Synthetic HPAPI
- Biotech HPAPI
- By Type of Manufacturers
- Captive or In-house manufacturers
- Merchant or Third party manufacturers
- By Type of Market
- Innovative
- Generic
In addition the
report provides a cross-sectional analysis of all the above segments
with respect to the following geographical markets:
- North America
- Europe
- Asia
- RoW
Browse
all Pharmaceutical Market Research Reports @
http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html
About
Us
Transparency
Market Research is a global market intelligence company, providing
global business information reports and services. Our exclusive blend
of quantitative forecasting and trends analysis provides
forward-looking insight for thousands of decision makers. We are
privileged with highly experienced team of Analysts, Researchers, and
Consultants, who use proprietary data sources and various tools and
techniques to gather, and analyze information.
Our
data repository is continuously updated and revised by a team of
research experts, so that it always reflects the latest trends and
information. With a broad research and analysis capability,
Transparency Market Research employs rigorous primary and secondary
research techniques in developing distinctive data sets and research
material for business reports.
Contact
Sheela
AK
90
State Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-618-1030
USA
- Canada Toll Free: 866-552-3453
No comments:
Post a Comment